Commutee

Pharma firm Gilead to raise Galapagos stake in $5.1 billion deal

July 14, 2019 by  
Filed under News

Gilead Sciences Inc will invest $5.1 billion to increase its stake in Galapagos NV and partner with the Belgian-Dutch biotech firm to develop and commercialize its treatments for a ten-year period, the companies said on Sunday.


Source: Reuters Business News

Comments are closed.